CR vs RMD · P/E 38, rev $2.31B vs P/E 29, rev $5.65B
Crane Company (CR) versus ResMed Inc (RMD) — a side-by-side from cached financials, not a winner call.
Crane Company (CR) is a specialty industrial machinery company listed on NYSE.
ResMed Inc (RMD) is a medical instruments & supplies company listed on US.
Latest reported CR revenue for 2025-12-31 was $2.31B. Net income was $366.6M. Revenue was up 323.6% from 2024-12-31 to 2025-12-31. CR currently screens at market cap $12.08B and trailing P/E 38.2.
Latest reported RMD revenue for 2026-06-30 was $5.65B. Net income was $1.52B. Revenue was up 9.9% from 2025-06-30 to 2026-06-30. RMD currently screens at market cap $37.68B and trailing P/E 28.8.
CR currently screens at market cap $12.08B and trailing P/E 38.2. RMD currently screens at market cap $37.68B and trailing P/E 28.8.
Not investment advice. Open the CR and RMD stock pages for the full models.
Not investment advice.